Originally developed for managing type 2 diabetes, they are now widely recognized for their significant impact on weight reduction
The good and bad of Nrf 2: an update in cancer and new perspectives in COVID-19
Cardiac Stress Test Evaluation of the heart's response to physical exertion or medication-induced stress
Weight loss improves knee OA, with studies showing a 2% improvement in the WOMAC pain, function, and stiffness scores for every 1% reduction in body weight
The failure of the Exenatide-PD3 and NLY01 trials has cast serious doubt on whether GLP-1 RAs have a future in PD
GLP-1 medication can be prescribed for weight management in adults with BMIs of 30 or over or with BMIs of 27 or over with at least one weight-related condition (hypertension, type 2 diabetes, obstructive sleep apnea, etc.)